Correction to: Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

IF 4.1 2区医学 Q2 ONCOLOGY

BMC Cancer Pub Date : 2026-08-12 DOI:10.1186/s12885-026-16657-0

Shaoyan Lin, Huaqiang Zhou, Gang Chen, Jinhui Xue, Qianwen Liu, Jianing Li, Yanhua Yang, Yuanyuan Zhao, Hua Bao, Yan Huang, Yuxiang Ma, Hongyun Zhao

引用次数: 0

查看原文本刊更多论文

更正：早期血浆eb病毒DNA载量和病毒溶酶基因组水平的变化可以积极预测接受抗程序性细胞死亡1单药治疗的复发或转移性鼻咽癌的临床结局。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Cancer 医学-肿瘤学

CiteScore

6.00

自引率

2.60%

发文量

1204

审稿时长

6.8 months

期刊介绍： BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.